CD8A and neoplasm: For example, loss of PD-L1 (programmed cell death 1 ligand 1), PDCD 1 (programmed cell death 1), CD38 molecule-adenosine receptor, and HLA-associated ligand-receptor interactions can inhibit CD8+ T cells’ tumor-killing function, respectively (10–12).